integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
WUBILTFDXIBJBG-FEFPCXJTSA-N
PE(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
WUBILTFDXIBJBG-FEFPCXJTSA-N
CHEBI:145854
0 Reactome links
2 studies
2
Observed studies
2
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
WUBILTFDXIBJBG-FEFPCXJTSA-N
InChI Key
WUBILTFDXIBJBG-FEFPCXJTSA-N
IUPAC name
Preferred name
PE(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
INN name
—
Synonym
PE 22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)
ChEBI
CHEBI:145854
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
Observed in differential profiles
G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
Control_vs_Exercise